Fumio Ishida
Overview
Explore the profile of Fumio Ishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyakita H, Yamamoto S, Uchino M, Hiroki I, Okabayashi K, Shiro O, et al.
Colorectal Dis
. 2025 Mar;
27(3):e70044.
PMID: 40025818
Aim: Ulcerative colitis (UC) is a known contributor to the development of colitis-associated cancer (CAC), although the exact mechanism remains to be elucidated. CAC typically presents as a flat type...
2.
Kakisako K, Mukai S, Ogata N, Koike C, Komai S, Matsudo S, et al.
Gan To Kagaku Ryoho
. 2024 Dec;
51(12):1267-1270.
PMID: 39721792
An 87-year-old man with complaints of palpitations and digestive bleeding previously visited another hospital. He was referred to our hospital because of anemia. Small bowel endoscopy revealed an elevated lesion...
3.
Mukai S, Sawada N, Takehara Y, Nakahara K, Enami Y, Ishida F, et al.
Heliyon
. 2024 Nov;
10(20):e39530.
PMID: 39502253
Background: Neoadjuvant therapy (NAT) before radical surgery are effective treatments for locally advanced rectal cancer. However, the treatment strategy after NAT and surgery is still unclear. It is difficult to...
4.
Ichimasa K, Foppa C, Kudo S, Misawa M, Takashina Y, Miyachi H, et al.
Ann Surg
. 2024 Jul;
280(5):850-857.
PMID: 39077765
Objective: To develop and externally validate an updated artificial intelligence (AI) prediction system for stratifying the risk of lymph node metastasis (LNM) in T2 colorectal cancer (CRC). Background: Recent technical...
5.
Yamashita K, Oka S, Yamada T, Mitsui K, Yamamoto H, Takahashi K, et al.
J Gastroenterol
. 2024 Feb;
59(5):376-388.
PMID: 38411920
Background: The clinicopathological features and prognosis of primary small bowel adenocarcinoma (PSBA), excluding duodenal cancer, remain undetermined due to its rarity in Japan. Methods: We analyzed 354 patients with 358...
6.
Nishikawa Y, Horimatsu T, Oka S, Yamada T, Mitsui K, Yamamoto H, et al.
JCO Glob Oncol
. 2024 Feb;
10:e2300392.
PMID: 38330276
Purpose: Limited information is available regarding the characteristics and outcomes of stage IV small bowel adenocarcinoma (SBA) in Japan. This study examined the clinical and pathological characteristics and outcomes according...
7.
Sawada N, Mukai S, Takehara Y, Misawa M, Kudo T, Hayashi T, et al.
Indian J Surg Oncol
. 2024 Jan;
14(4):765-772.
PMID: 38187830
The present study examined the therapeutic effects of preoperative neoadjuvant chemoradiation therapy (NACRT) and predictive factors for complete clinical remission, compared the prognosis and costs of abdominoperineal resection (APR) and...
8.
Shiina O, Kudo S, Ichimasa K, Takashina Y, Kouyama Y, Mochizuki K, et al.
DEN Open
. 2023 Dec;
4(1):e324.
PMID: 38155928
Objectives: Japanese guidelines include high-grade (poorly differentiated) tumors as a risk factor for lymph node metastasis (LNM) in T1 colorectal cancer (CRC). However, whether the grading is based on the...
9.
Kato S, Kudo S, Minegishi Y, Miyata Y, Maeda Y, Kuroki T, et al.
Dig Endosc
. 2023 Nov;
36(3):341-350.
PMID: 37937532
Objectives: Computer-aided characterization (CADx) may be used to implement optical biopsy strategies into colonoscopy practice; however, its impact on endoscopic diagnosis remains unknown. We aimed to evaluate the additional diagnostic...
10.
Enami Y, Aoki T, Tomioka K, Hirai T, Shibata H, Saito K, et al.
Cancer Diagn Progn
. 2023 Sep;
3(5):571-576.
PMID: 37671304
Background/aim: According to the Tokyo Guidelines 2018, the operation for acute cholecystitis is recommended to be performed as early as possible. However, there are cases in which early surgeries cannot...